| Identification | Back Directory | [Name]
L-Lysine, glycyl-L-tyrosyl-N6-[N-[2-[[2-[bis(carboxymethyl)amino]ethyl](carboxymethyl)amino]ethyl]-N-(carboxymethyl)glycyl]- | [CAS]
148805-91-8 | [Synonyms]
L-Lysine, glycyl-L-tyrosyl-N6-[N-[2-[[2-[bis(carboxymethyl)amino]ethyl](carboxymethyl)amino]ethyl]-N-(carboxymethyl)glycyl]- | [Molecular Formula]
C31H47N7O14 | [MOL File]
148805-91-8.mol | [Molecular Weight]
741.74 |
| Hazard Information | Back Directory | [Uses]
Pendetide is a chelating agent, can be conjugated with Indium (111In) Capromab for further diagnostic use. Capromab pendetide is a FDA-approved imaging agent for the detection of soft tissue metastases in prostate carcinoma[1]. Pendetide can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs). | [References]
[1] Ganesh V Raj, et al. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. Cancer. 2002 Feb 15;94(4):987-96. PMID:11920467 |
|
|